Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment.

Hidenari NagaiTakanori MukozuTeppei MatsuiKunihide MohriHideki NagumoNaoyuki YoshimineKojiro KobayashiYu OginoYasuko DaidoNoritaka WakuiKoichi MomiyamaTakahisa MatsudaYoshinori IgarashiKoji Higai

Published in: Oncology (2024)

These findings reveal a need to further improve T-cell priming and to further make T-cells recognize tumor antigens in uHCC.

Keyphrases

genome wide
dendritic cells
single cell
locally advanced
gene expression
combination therapy
metastatic colorectal cancer
liver metastases
squamous cell carcinoma
immune response
dna methylation
rectal cancer